Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications.

[1]  S. Bertog,et al.  Incomplete left atrial appendage occlusion and thrombus formation after Watchman implantation treated with anticoagulation followed by further transcatheter closure with a second‐generation Amplatzer Cardiac Plug (Amulet device) , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  Dhanunjaya R. Lakkireddy,et al.  Initial experience with post Lariat left atrial appendage leak closure with Amplatzer septal occluder device and repeat Lariat application. , 2014, Heart rhythm.

[3]  P. Neužil,et al.  Multicenter study on acute and long-term safety and efficacy of percutaneous left atrial appendage closure using an epicardial suture snaring device. , 2014, Heart rhythm.

[4]  M. Price,et al.  Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium. , 2014, Journal of the American College of Cardiology.

[5]  Anil K Gehi,et al.  Left atrial thrombus after appendage ligation with LARIAT. , 2014, Heart rhythm.

[6]  M. Price,et al.  Percutaneous management of late leak after lariat transcatheter ligation of the left atrial appendage in patients with atrial fibrillation at high risk for stroke , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  Dhanunjaya R. Lakkireddy,et al.  Left atrial appendage occlusion: opportunities and challenges. , 2014, Journal of the American College of Cardiology.

[8]  K. Chun,et al.  Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience. , 2013, Heart rhythm.

[9]  Lennart Bergfeldt,et al.  Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited: A Population-Based Study , 2013, Stroke.

[10]  D. Lane,et al.  Comparison of the CHADS2, CHA2DS2 -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial , 2013, Thrombosis and Haemostasis.

[11]  B. Knight,et al.  Left atrial thrombus after appendage closure using LARIAT. , 2013, Circulation. Arrhythmia and electrophysiology.

[12]  Frederick T. Han,et al.  Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. , 2013, Journal of the American College of Cardiology.

[13]  Petr Neuzil,et al.  Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). , 2013, Journal of the American College of Cardiology.

[14]  A. Massumi,et al.  Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. , 2013, The American journal of cardiology.

[15]  Apixaban versus Warfarin in Patients with Atrial Fibrillation , 2012 .

[16]  G. Breithardt,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[17]  Bernhard Meier,et al.  Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[18]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[19]  H. Alkadhi,et al.  Left atrial appendage clip occlusion: early clinical results. , 2010, The Journal of thoracic and cardiovascular surgery.

[20]  V. Reddy,et al.  Percutaneous left atrial appendage closure with an epicardial suture ligation approach: a prospective randomized pre-clinical feasibility study. , 2010, Heart rhythm.

[21]  A. Rabinstein.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2010 .

[22]  Leon Poller,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[23]  Maurice Buchbinder,et al.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.

[24]  G. Schuler,et al.  Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. , 2007, Journal of the American College of Cardiology.

[25]  B. Gage,et al.  Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation , 2006, Stroke.

[26]  B. Gage,et al.  Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin , 2004, Circulation.

[27]  D. Levy,et al.  Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.

[28]  D. Packer,et al.  Left Atrial Appendage Obliteration in Atrial Fibrillation Thoracoscopic Extracardiac Obliteration of the Left Atrial Appendage for Stroke Risk Reduction in Atrial Fibrillation , 2003 .

[29]  I. Kronzon,et al.  Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. , 2000, Journal of the American College of Cardiology.

[30]  A. Camm,et al.  Left atrial appendage: structure, function, and role in thromboembolism , 1999, Heart.

[31]  C. Visser,et al.  Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation. , 1999, European heart journal.

[32]  A. Sheikhzadeh,et al.  Detection of a Hypercoagulable State in Nonvalvular Atrial Fibrillation and the Effect of Anticoagulant Therapy , 1996, Thrombosis and Haemostasis.

[33]  J. Odell,et al.  Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. , 1996, The Annals of thoracic surgery.

[34]  N. Ammash,et al.  Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographics tudy , 1995 .

[35]  N. Ammash,et al.  Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. , 1995, Journal of the American College of Cardiology.

[36]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[37]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.